BluDerma
Diva Eyes

Lexyal

Diva Eyes

Brand

Lexyal

Category

Skin Booster

Origin

Korea

Interested in ordering Diva Eyes? Send an enquiry and our team will follow up with availability and pricing.

Overview

Diva Eyes (Lexyal Diva Eyes) is a polynucleotide (PN) skinbooster formulated for the delicate under-eye area. It combines salmon-derived PN with hyaluronic acid, delivered by fine microinjection to hydrate, regenerate and improve the appearance of dark circles and fine lines rather than to volumise. It is designed for periorbital skin-quality rejuvenation.

How it works

Polynucleotide from salmon DNA supports fibroblast activity and collagen regeneration, strengthening thin under-eye skin, while hyaluronic acid provides hydration and improves surface quality. Together they refine texture, support elasticity and help improve the look of dark shadows and crepey fine lines around the eyes.

Indications

  • Dark circles and under-eye shadowing
  • Fine lines and crepey periorbital skin
  • Under-eye dehydration
  • Loss of elasticity around the eyes
  • Dull, tired-looking eye contour

Key features

  • PN + HA formulation for periorbital skin
  • Targets thin, delicate under-eye tissue
  • Hydration and regeneration focused
  • Non-volumising liquid profile
  • Companion product to Diva Face

Benefits

  • Dedicated under-eye option expands the eye-treatment menu
  • Combines hydration and regeneration in one product
  • Supports protocols for tired, shadowed under-eyes
  • Course-based use drives repeat appointments
  • Bundles naturally with a full-face PN booster

Composition

Polynucleotide (PN) from salmon DNA combined with hyaluronic acid (periorbital formulation).

Usage & handling

Professional use only. Delivered by superficial microinjection / mesotherapy to the under-eye and tear-trough area. Store protected from light per manufacturer guidance; do not freeze.

For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.